MSD and Eisai’s LEAP gastroesophageal cancer trial sees mixed success
MSD and Eisai have announced mixed results from a Phase III trial of a Keytruda (pembrolizumab) combination as a first-line…
News
Allurion shares soar 77% after sharing plans for GLP-1RA combo trial
Traws Pharma completes Phase I trials of H5N1 bird flu treatment drug
Rakuten doses first patients in multi-continental Phase III HNSCC trial
Genprex doses first subject in expansion part of lung cancer gene therapy trial
Medidata extends partnership with Tigermed to enhance clinical trial processes
Lunit’s SCOPE AI tools demonstrate value in HER2 biomarker evaluation
First patient dosed in Phase Ib Pompe disease trial
